Antibiotice Ia (ATB) — Cash Flow Reinvestment Rate
Antibiotice Ia (ATB) has a Cash Flow Reinvestment Rate of 0.35x as of December 2025, reinvesting RON13.33 Million (capex RON13.33 Million ) from operating cash flow of RON37.61 Million. Explore reinvestment intensity of Antibiotice Ia to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Antibiotice Ia Cash Flow Reinvestment Rate (2022–2025)
Historical reinvestment intensity for Antibiotice Ia across 4 annual periods. Also explore Antibiotice Ia (ATB) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Antibiotice Ia (2022–2025)
Year-by-year capital reinvestment analysis for Antibiotice Ia. For live market cap and broader valuation context, see Antibiotice Ia (ATB) total market value.
| Year | Reinvestment Rate | Total Reinvested (RON) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.97x | RON142.61 Million | RON72.44 Million | RON142.61 Million | ▼ -19.4% |
| 2024 | 2.44x | RON232.32 Million | RON95.15 Million | RON116.16 Million | ▲ +52.5% |
| 2023 | 1.60x | RON196.07 Million | RON122.46 Million | RON98.04 Million | ▲ +132.2% |
| 2022 | 0.69x | RON79.76 Million | RON115.66 Million | RON39.88 Million | — |